Stig Michael Sundström
No más puestos en curso
Origen de la red de primer grado Stig Michael Sundström.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Financial Conglomerates | 18 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Stig Michael Sundström a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Greenlight Capital, Inc.
 Greenlight Capital, Inc. Investment ManagersFinance Greenlight Capital, Inc. is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by David Einhorn in 1996. Greenlight Capital provides investment advisory services to the Greenlight “Capital Funds”. | Investment Managers | Analyst-Equity | |
| SPICERS LTD | Wholesale Distributors | Director/Board Member | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Chairman Director/Board Member | |
| MEDA AB | Pharmaceuticals: Major | Chairman | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Sjunde AP-fonden
 Sjunde AP-fonden Investment ManagersFinance Sjunde AP-fonden (AP7), locally known as The Seventh Swedish National Pension Fund, is the State-owned pension fund management firm which was founded by the Swedish parliament in 2000. Headquartered in Stockholm, AP7 is responsible for managing premium pension funds for the Swedish people. They are the only state actor in the premium pension system that provides the fund portfolio AP7 Såfa. AP7 Såfa is the state alternative to the private investment funds offered within the Swedish premium pension system. The firm is responsible to the management of these funds and provides a return that is at least as good as the average of the private investment funds in the system. | Investment Managers | Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
| OREXO AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Stockholm School of Economics | College/University | Undergraduate Degree Undergraduate Degree | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chairman Director of Finance/CFO Private Equity Investor | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
| REDBANK ENERGY LTD | Electric Utilities | Director/Board Member | |
| Sodertorn University | College/University | Chairman | |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
KDev Exploratory AB
 KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Biotechnology | Chief Executive Officer | |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Founder | |
Coastal Investment Management LLC
 Coastal Investment Management LLC Investment ManagersFinance Coastal Investment Management LLC provides investment advisory services. The company was founded by Vlad Artamonoy and Todd Plutsky in July 2009 and is headquartered in New York, NY. | Investment Managers | Founder | |
| LIPIDOR AB | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
| KCIF Fund Management AB | Chief Executive Officer Chief Executive Officer | ||
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Chairman | |
| QLUCORE AB | Packaged Software | Director/Board Member | |
| Baltic Sea Foundation | Chairman | ||
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
Coastal Capital International Ltd.
 Coastal Capital International Ltd. Financial ConglomeratesFinance Coastal Capital International Ltd. is headquartered in George Town, KY. | Financial Conglomerates | Director/Board Member | |
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Director/Board Member Director/Board Member | |
| Analgesia Partnership | Corporate Officer/Principal | ||
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin | |
Disruptive Materials AB
 Disruptive Materials AB Chemicals: Major DiversifiedProcess Industries Disruptive Materials AB manufactures mesoporous magnesium carbonate. It focuses on commercializing the material Upsalite that can be used in applications such as desiccant for humidity control, pharmaceutics, adsorbent for waste handling, thermal and acoustic insulation, cosmetics, adsorbent in ink jet paper,and bio material applications. The company was founded by Johan A. V. Gómez de la Torre, Maria Strømme, Lars-Erik Mattias Karls, and Sara Kristina Frykstrand Ångström in December 2011 and is headquartered in Uppsala, Sweden. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
| GABATHER AB | Pharmaceuticals: Major | Director/Board Member | |
| CORLINE BIOMEDICAL AB | Medical Specialties | Director/Board Member | |
Immuneed AB
 Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Medical Specialties | Chief Executive Officer | |
| EMPLICURE AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
| SP Process Development AB | Director/Board Member | ||
Allmora Life Science AB
 Allmora Life Science AB Forest ProductsNon-Energy Minerals Allmora Life Science AB is a Swedish company that operates sawmills. The private company is based in Stockholm, Sweden. The CEO of the company is Charlotte Elisabet Edenius. | Forest Products | Chief Executive Officer | |
Haracon AB
 Haracon AB Miscellaneous Commercial ServicesCommercial Services Haracon AB provides corporate consulting services. | Miscellaneous Commercial Services | Director/Board Member | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Founder |
Estadísticas
Internacional
| Suecia | 36 |
| Estados Unidos | 7 |
| Dinamarca | 4 |
| Australia | 3 |
| Italia | 2 |
Sectorial
| Health Technology | 22 |
| Finance | 10 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Distribution Services | 2 |
Operativa
| Director/Board Member | 163 |
| Chairman | 41 |
| Independent Dir/Board Member | 34 |
| Corporate Officer/Principal | 27 |
| Director of Finance/CFO | 17 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Stig Michael Sundström
- Conexiones Empresas
